Journal
NATURE IMMUNOLOGY
Volume 8, Issue 7, Pages 753-761Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni1472
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI059475, AI47231, AI040215] Funding Source: Medline
Ask authors/readers for more resources
How vaccines control the development of antigen-specific effector and memory T helper cells is central to protective immunity but remains poorly understood. Here we found that protein vaccination selected high-affinity, CXCR5(+)ICOS(hi) follicular B-helper T cells (T-FH cells) that developed in draining lymphoid tissue to regulate B cell responses. In the memory phase, reservoirs of antigen-specific CXCR5(+)ICOS(lo) T-FH cells persisted with less effector activity but accelerated antigen-recall ability. This new compartment of memory T-FH cells was retained in draining lymphoid sites with antigen-specific memory B cells, persistent complexes of peptide and major histocompatibility complex class II and continued expression of CD69. Thus, protein vaccination promotes B cell immunity by selecting high-affinity effector T-FH cells and creating lymphoid reservoirs of antigen-specific memory T-FH cells in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available